Esophageal Cancer Metastatic

1 clinical trials · Condition

Record	Firm	Date
A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer (NCT03416244)	AIO-Studien-gGmbH	2018-02-21

Every clearance here is in the API, with alerts when new ones post.